From: Validation of the functional assessment of cancer therapy-gastric module for the Chinese population
 | Treatment intent | Clinical stage* | ||||||
---|---|---|---|---|---|---|---|---|
 | Curative (n = 48) | Palliative (n = 19) | Effect size | P | Early stage (n = 49) | Late stage (n = 18) | Effect size | P |
 | Mean ± SD | Mean ± SD |  |  | Mean ± SD | Mean ± SD |  |  |
PWB | 24.8 (3.90) | 23.1 (4.36) | 0.45 | 0.112 | 24.7 (4.01) | 23.4 (4.24) | 0.32 | 0.264 |
SWB | 21.3 (5.86) | 21.9 (4.34) | −0.10 | 0.686 | 20.9 (5.94) | 23.1 (3.48) | −0.36 | 0.079 |
EWB | 20.6 (2.95) | 18.7 (4.11) | 0.65 | 0.036 | 20.4 (2.97) | 19.3 (4.38) | 0.36 | 0.256 |
FWB | 20.6 (6.26) | 16.0 (6.31) | 0.74 | 0.008 | 19.9 (6.52) | 17.5 (6.60) | 0.37 | 0.180 |
GCS | 61.4 (11.59) | 56.1 (13.1) | 0.46 | 0.106 | 61.8 (10.95) | 54.8 (14.10) | 0.64 | 0.035 |
FACT-G | 87.4 (13.77) | 79.6 (15.30) | 0.56 | 0.049 | 85.9 (14.57) | 83.2 (14.70) | 0.18 | 0.511 |
FACT-Ga | 148.5 (22.76) | 135.2 (6.77) | 0.59 | 0.044 | 147.4 (22.99) | 137.5 (27.70) | 0.43 | 0.146 |
EQ-5D | 0.86 (0.24) | 0.65 (0.33) | 0.89 | 0.016 | 0.84 (0.25) | 0.68 (0.33) | 0.66 | 0.031 |